|
Volumn 11, Issue 3, 2001, Pages 395-398
|
Synthesis and antifungal activities of novel 1,3-β-D-glucan synthase inhibitors. Part 1
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,3 BETA GLUCAN SYNTHASE;
1,3 BETA GLUCAN SYNTHASE INHIBITOR;
ENZYME INHIBITOR;
ETHYLAMINE;
FR 901469;
FUNGICIDE;
LACTONE DERIVATIVE;
LIPOPEPTIDE;
MACROCYCLIC COMPOUND;
MACROCYCLIC LIPOPEPTIDOLACTONE;
N,N BIS(2 AMINOETHYL) DERIVATIVE;
ORNITHINE DERIVATIVE;
RO 09 3655;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIFUNGAL ACTIVITY;
ARTICLE;
CANDIDIASIS;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DRUG IDENTIFICATION;
DRUG POTENCY;
DRUG SYNTHESIS;
LIVER TOXICITY;
MOUSE;
NONHUMAN;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTIBIOTICS, ANTIFUNGAL;
CANDIDA ALBICANS;
CANDIDIASIS;
COMBINATORIAL CHEMISTRY TECHNIQUES;
DISEASE MODELS, ANIMAL;
ENZYME INHIBITORS;
GLUCOSYLTRANSFERASES;
INCLUSION BODIES;
INHIBITORY CONCENTRATION 50;
LACTONES;
LIVER;
MEMBRANE PROTEINS;
MICE;
MICROBIAL SENSITIVITY TESTS;
PEPTIDES;
SCHIZOSACCHAROMYCES POMBE PROTEINS;
STRUCTURE-ACTIVITY RELATIONSHIP;
SURVIVAL RATE;
THERAPEUTIC EQUIVALENCY;
|
EID: 0035847660
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(00)00678-8 Document Type: Article |
Times cited : (21)
|
References (14)
|